Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mattia Fleres"'
Autor:
Alessandro Scorsone, Gabriella Saura, Mattia Fleres, Lucia Spano, Vito Aiello, Davide Brancato, Anna Di Noto, Francesca Provenzano, Vincenzo Provenzano
Publikováno v:
Journal of Diabetes Research, Vol 2018 (2018)
Introduction. This study aimed at evaluating the efficacy and safety of dapagliflozin in patients with type 2 diabetes (T2D) who also received metformin in clinical practice in Italy. Methods. This was a retrospective observational study and it inclu
Externí odkaz:
https://doaj.org/article/8128f26956d64928a776e40f8933dbc9
Autor:
VINCENZO PROVENZANO, DAVIDE BRANCATO, MATTIA FLERES, FRANCESCA PROVENZANO, ANNA R. SALVAGGIO, ALESSANDRO SCORSONE
Publikováno v:
Diabetes. 71
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been hypothesized to exert beneficial effects on COVID-19 outcomes due to their anti-inflammatory properties. In our COVID-19 ward, patients admitted for severe interstitial bilateral pneumon
Autor:
Anna Di Noto, Lucia Spano, Mattia Fleres, Gabriella Saura, Alessandro Scorsone, Vito Aiello, Vincenzo Provenzano, Davide Brancato, Francesca Provenzano
Publikováno v:
Journal of Diabetes Research
Journal of Diabetes Research, Vol 2018 (2018)
Journal of Diabetes Research, Vol 2018 (2018)
Introduction. This study aimed at evaluating the efficacy and safety of dapagliflozin in patients with type 2 diabetes (T2D) who also received metformin in clinical practice in Italy. Methods. This was a retrospective observational study and it inclu
Autor:
Vincenzo Provenzano, Davide Brancato, Anna Di Noto, Mattia Fleres, Vito Aiello, Lidia Ferrara, Alessandro Scorsone, Lucia Spano, Gabriella Saura
Publikováno v:
Diabetes Technology & Therapeutics. 15:580-585
The purpose of this study is to evaluate continuous glucose monitoring (CGM) in predicting diabetes mellitus in children with incident hyperglycemia (IH) and negativity for some insular autoantibodies.Thirty-one autoantibody-negative children who pre
Autor:
Anna Di Noto, Gabriella Saura, Lidia Ferrara, Vito Aiello, Vincenzo Provenzano, Mattia Fleres, Alessandro Scorsone, Davide Brancato
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 20(7)
A great number of factors can interfere with levothyroxine (LT4) tablet absorption, leading to increased serum thyroid-stimulating hormone (TSH) levels and, accordingly, to increased LT4 requirements. LT4 oral solution (LT4-OS) is a novel formulation